Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
"... the opportunities to use risk sharing agreements in theRussian Federation, taking into consideration the existing ..."
 
Vol 8, No 2 (2015) REVIEW OF THE INTERNATIONAL PRACTICE OF COST-SHARING MECHANISM IN NATIONAL HEALTH CARE SYSTEMS Abstract  similar documents
Natalia Nikolayevna Sisigina, Vitalii Vladimirovich Omel'yanovskii, Nikolay Alexandrovich Avxentyev
"... to prevent the risk of patient’s moral hazard. Theoretical background and types of cost-sharing, protection ..."
 
Vol 10, No 3 (2017) The strategies of drug supply for patients with chronic hepatitis C Abstract  similar documents
E. V. Kornilova, A. D. Ermolaeva, M. G. Rusanova, D. A. Andreev, M. V. Davydovskaya, T. N. Ermolaeva, A. g Pokatilo, K. I. Polyakova, V. A. Dubovtseva, K. А. Kokushkin, A. V. Devyatkin
 
Vol 9, No 3 (2016) COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE Abstract  similar documents
A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii
"... по разделению рисков: возможности применения в Российской Федерации � Определение основных видов ..."
 
Vol 6, No 3 (2013) METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES Abstract  similar documents
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze
"... исследований полезности проводится с использованием метода «стандартных рисков», считающегося классическим ..."
 
Vol 9, No 4 (2016) FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING Abstract  similar documents
O. A. Zarubina, N. N. Sisigina
"... health expenditure, regulatory measures on cost sharing, paid medical services, voluntary health ..."
 
Vol 12, No 2 (2019) Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU Abstract  similar documents
G. N. Gildeeva, A. V. Belostotsky
"... ) and risk management plans (RMP) was also carried out. Results. The united EAEU drug market is a complex ..."
 
Vol 7, No 2 (2014) THE ANALYSIS OF THE EFFECTIVENESS OF THROMBOPROPHYLAXIS AMONG PREGNANT WOMEN WITH MESENCHYMAL DYSPLASIA Abstract  similar documents
E. G. Kudinova, A. P. Momot, N. V. Trukhacheva
"... dysplasia was carried out. It was concluded that it reduces the risk of thrombohemorrhagic complications ..."
 
Vol 11, No 1 (2018) Medical care of ambulatory patients and its assessment: a review of international experience Abstract  similar documents
D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky
"... in outpatients. General approaches, benefits, risks and other criteria of quality assessment are described. ..."
 
Vol 10, No 4 (2017) THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT Abstract  similar documents
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov
"... The paper examines the international experience of drug supply and the risks faced by countries ..."
 
Vol 9, No 3 (2016) EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov
"... . Dabigatran increased major bleeding risk compared to apixaban RR=2.36; 95% CI 1.15-4.82 and the risk major ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... the application dalteparin in comparison with other low-molecular-weight heparins in patients with high risk ..."
 
Vol 8, No 1 (2015) SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION Abstract  similar documents
A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova
"... of disease) of five natural focal transmitted infectious diseases in theRussian Federationon the whole ..."
 
Vol 8, No 1 (2015) DEFINING THE MAIN TYPES OF RESEARCH AND DEVELOPMENT FOR PURPOSES OF SHAPING STATE R&D POLICY IN RUSSIA AND IN OECD COUNTRIES Abstract  similar documents
O. V. Bogacheva, O. A. Feoktistova
"... state policy formulation in the area of R&D in theRussian Federationand to propose respective amendments ..."
 
Vol 6, No 2 (2013) FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS Abstract  similar documents
A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure
"... : Existing type 2 DM models were evaluated. Risk equations for type 2 DM complications were compiled ..."
 
Vol 8, No 2 (2015) REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS Abstract  similar documents
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
"... , risk management, and international rare diseases patient registries could be used to solve ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... применении таких инновационных подходов, как соглашения о разделения рисков и затрат, ранняя ОТЗ и ..."
 
Vol 5, No 2 (2012) WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM Abstract  similar documents
A. I. Borodin
"... and inflation generate risks, both for firm, and for its foreign partners. For the purpose of optimum strategy ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
"... alternative for patients with highly active MS and patients with a high risk of progressive multifocal ..."
 
Vol 8, No 4 (2015) ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS Abstract  similar documents
A. N. Korobeynikova, S. V. Malchikova
"... in practice, leading to an increased risk of death, stroke, heart failure. The results of pharmacoeconomical ..."
 
Vol 11, No 4 (2018) Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease Abstract  similar documents
V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev
"... of the enzyme α-galactosidase A and characterized by the risk of renal failure combined with cardiovascular ..."
 
Vol 12, No 3 (2019) Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia Abstract  similar documents
V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina
"... obstacles and risks for their implementation. Materials and methods. We reviewed documents and publications ..."
 
Vol 7, No 2 (2014) CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM Abstract  similar documents
I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek
"... risk factor for poor prognosis in stable angina. The aim of the research: assessment of the economic ..."
 
Vol 12, No 2 (2019) Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava
"... - by 1 g/day was associated with a significant decrease in the risk of mortality by an average of 5 ..."
 
Vol 12, No 2 (2019) New framework for the development of clinical guidelines in Russia Abstract  similar documents
D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov
"... that it would be advisable to implement the system called GRADE. In addition, possible legal risks are analyzed ..."
 
Vol 6, No 2 (2013) HTA CORE MODEL Abstract  similar documents
R. I. Yagudina, T. Yu. Nor, A. D. Sevostyanov
"... любой точке охваченной программой территории. В основе Базовой модели ОТЗ лежит принцип разделения ..."
 
Vol 11, No 4 (2018) Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense Abstract  similar documents
D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy
"... and regulations of healthcare for servicepersons and other staff within the Ministry of Defense of theRussian ..."
 
Vol 10, No 4 (2017) PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... in negative outcomes: i.e. by 62.1% and 62.4% for the risk of bleedings and targeted joints (respectively ..."
 
Vol 5, No 3 (2012) COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES Abstract  similar documents
M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova
"... пациенты с НППО были разделены на две группы. Пациенты первой (основной) группы получали курс внутрикостных ..."
 
Vol 8, No 2 (2015) CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA Abstract  similar documents
Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova
"... среднетяжелого течения, обоего пола, которые в зависимости от проводимой терапии были разделены на четыре группы ..."
 
Vol 10, No 1 (2017) CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS Abstract  similar documents
P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova
"... , in theRussian Federation. Materials and Methods. Direct, indirect and meta-analytic comparisons were applied ..."
 
Vol 10, No 1 (2017) BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS Abstract  similar documents
E. A. Pyadushkina
"... . Since Vedolizumab has been just recently registered in theRussian Federation and it is yet ..."
 
Vol 10, No 3 (2017) Decision modelling for the evaluation of diabetes outcomes Abstract  similar documents
A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin
"... , empagliflozin) capable of significantly reducing cardiovascular risks in DM patients, require new approaches ..."
 
Vol 8, No 1 (2015) PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE Abstract  similar documents
D. V. Blinov, U. V. Zimovina, T. I. Ushakova
"... � Оплата новых дорогостоящих технологий в здравоохранении на основе соглашений по разделению ..."
 
Vol 7, No 1 (2014) ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY Abstract  similar documents
T. L. Galankin, A. S. Kolbin
"... редких НЯ (таких как агранулоцитоз), или о частоте отсроченных НЯ (например, повышенние риска развития ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
"... � Оплата новых дорогостоящих технологий в здравоохранении на основе соглашений по разделению ..."
 
Vol 9, No 4 (2016) PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) Abstract  similar documents
D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov
"... НАЖБП и высоким риском развития сердечно-сосудистых событий, что неоднократно подтверждалось в ходе ..."
 
Vol 9, No 1 (2016) COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN Abstract  similar documents
V. I. Petrov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, V. Yu. Khripaeva
"... значительно увеличивает риск развития связанных с СД осложнений. Во многих случаях для контроля глюкозы в ..."
 
Vol 7, No 1 (2014) PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE Abstract  similar documents
S. A. Rachina, R. S. Kozlov, Yu. A. Belkova
"... соотношение поль- зы/риска применения ЛС [15,35,41]. Исследования «случай-контроль» (case-control studies). В ..."
 
Vol 9, No 2 (2016) EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 Abstract  similar documents
V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov
"... оценивалась распространен- ность факторов риска НАЖБП и определялась оценка их значимо- сти по частоте ..."
 
Vol 8, No 4 (2015) ABC-, VEN и частотный анализ терапии фибрилляции предсердий в условиях «типичной практики» Abstract  similar documents
"... в практике аритмия, ведущая  к  увеличению риска смерти, острого нарушения мозгового кровообращения ..."
 
Vol 9, No 3 (2016) Эффективность и безопасность пероральных антикоагулянтов при венозных тромбоэмболических осложнениях: непрямые сравнения Abstract  similar documents
"... эффективность, включая ВТЭО, тромбоз глубоких вен и тромбоэмбо-лию легочной артерии не выявлено. Риск развития ..."
 
Vol 7, No 1 (2014) EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE Abstract  similar documents
M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov
"... детей. Твердые ЛС измельчаются, содер- жимое капсул смешивается с жидкостью, пищей, повышая риск ..."
 
Vol 5, No 3 (2012) CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE Abstract  similar documents
E. E. Arinina, M. A. Rashyd
"... ) повышен риск заболеваемости и смертности в сравнении с остальной попу- ляцией. В связи с развитием ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET Abstract  similar documents
R. I. Yagudina, V. G. Serpik
"... проведены исследования, связывающие риск смертности с че- тырьмя биохимическими параметрами, определяющими ..."
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract  similar documents
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
"... [10] и риск сердечно-сосудистых осложнений [21]. Метилк- сантины эффективны при ХОБЛ, но в связи с ..."
 
Vol 6, No 4 (2013) Using indirect comparisons in pharmacoeconomic examination Abstract  similar documents
Yu. E. Balykina, A. S. Kolbin
"... , отношение угроз (в анализе выживаемости) [12,18]. Относительный риск (relative risk – RR): RR BC = R AC ..."
 
Vol 9, No 2 (2016) MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE Abstract  similar documents
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya
"... эффективных и неэффективных операций [6]. Процессный подход предполагает разделение всей цепи сопри ..."
 
Vol 7, No 4 (2014) IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? Abstract  similar documents
V. V. Omelyanovskiy
"... соглашениями понимают согла- шения о разделении рисков, они могут основываться на достиже- нии финансовых ..."
 
Vol 6, No 3 (2013) ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION Abstract  similar documents
A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova
"... � Методологические основы использования метода «стандартных рисков» при оценке качества жизни в ..."
 
1 - 50 of 116 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)